Log in to save to my catalogue

Polyoxometalate-based injectable coacervate inhibits HCC metastasis after incomplete radiofrequency...

Polyoxometalate-based injectable coacervate inhibits HCC metastasis after incomplete radiofrequency...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b7b9f3ee2672436aaa6cb44f8d0f8138

Polyoxometalate-based injectable coacervate inhibits HCC metastasis after incomplete radiofrequency ablation via scavenging ROS

About this item

Full title

Polyoxometalate-based injectable coacervate inhibits HCC metastasis after incomplete radiofrequency ablation via scavenging ROS

Publisher

England: BioMed Central Ltd

Journal title

Journal of nanobiotechnology, 2025-01, Vol.23 (1), p.47-17, Article 47

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Incomplete radiofrequency ablation (iRFA) stimulates residual hepatocellular carcinoma (HCC) metastasis, leading to a poor prognosis for patients. Therefore, it is imperative to develop an effective therapeutic strategy to prevent iRFA-induced HCC metastasis.
Our study revealed that iRFA induced an abnormal increase in ROS levels within residual...

Alternative Titles

Full title

Polyoxometalate-based injectable coacervate inhibits HCC metastasis after incomplete radiofrequency ablation via scavenging ROS

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b7b9f3ee2672436aaa6cb44f8d0f8138

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b7b9f3ee2672436aaa6cb44f8d0f8138

Other Identifiers

ISSN

1477-3155

E-ISSN

1477-3155

DOI

10.1186/s12951-024-02989-1

How to access this item